Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients - A Prospective Cohort Study*

By Crowther M.A.   Spitzer K.   Julian J.   Ginsberg J.   Johnston M.   Crowther R.   Laskin C.  

Thrombosis Research, Vol. 98, Iss. 2, 2000-04 ,pp. : 133-138

Elsevier

Access to resources Recommend Favorite

Low–Molecular-Weight-Heparins as Periprocedural Anticoagulation for Patients on Long-Term Warfarin Therapy: A Standardized Bridging Therapy Protocol

By Jaffer Amir   Ahmed Mudassar   Brotman Daniel   Bragg Lee   Seshadri Niranjan   Qadeer Mohammed   Klein Allan  

Journal of Thrombosis and Thrombolysis, Vol. 20, Iss. 1, 2005-08 ,pp. : 11-16

Springer Publishing Company

Access to resources Recommend Favorite

Antithrombotic therapies in patients with prosthetic heart valves: guidelines translated for the clinician

By Leiria Tiago  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 514-522

Springer Publishing Company

Access to resources Recommend Favorite

Pulmonary Embolism in Medical Patients: Improved Diagnosis and the Role of Low-Molecular-Weight Heparin in Prevention and Treatment

By Merli Geno J.  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 2, 2004-10 ,pp. : 117-125

Springer Publishing Company

Access to resources Recommend Favorite

Early discharge and home supervision of patients with pulmonary embolism treated with low-molecular weight heparin

By Lim A.Y.H.   Parr D.G.   Stableforth D.E.   Fellows M.   Fontaine R.   Fegan C.D.  

European Journal of Internal Medicine, Vol. 14, Iss. 2, 2003-03 ,pp. : 89-93

Elsevier

Access to resources Recommend Favorite